Supernova 2

Micropep Technologies is an agricultural biotechnology company founded in 2016 and based in Toulouse, France. The company specializes in the development of non-GMO bioherbicides and biostimulants utilizing its innovative miPEP technology, which harnesses naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep focuses on four key development programs: germination, flowering, growth, and weed control, aiming to improve agricultural yields while maintaining the integrity of plant DNA. By leveraging the potential of these biomimetic peptides, Micropep seeks to provide effective solutions for managing plant genetics and enhancing resistance to diseases, thereby supporting sustainable farming practices.

Diabeloop is a medical device company based in Grenoble, France, specializing in innovative solutions for diabetes management. Founded in 2015, the company focuses on developing a closed-loop system that automates insulin delivery for individuals with type 1 diabetes. Its AI-based blood sugar monitoring device integrates a sensor that continuously measures glucose levels, a pump that administers insulin, and a smartphone application that connects these components through an embedded algorithm. This technology aims to enhance the treatment experience by reducing the mental burden on patients, allowing them to manage their condition more effortlessly and live their lives with greater freedom.

Founded in 2015, Unseenlabs specializes in marine surveillance services. It designs and develops satellite payloads to detect and track non-cooperative vessels worldwide, even when they disable their Automatic Identification System. The company offers turnkey solutions, providing information from satellite design to launch.

Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, specializing in the design and production of amorphous metal parts. Founded in 2017, Vulkam focuses on creating biocompatible amorphous metal alloys primarily composed of zirconium, copper, hafnium, nickel, and titanium. The company's innovative products serve various industries, including aerospace, automotive, biomedical, and microcomponents. Vulkam's micromechanical parts are notable for their small size and exceptional strength, offering performance comparable to established industry standards. By leveraging advanced materials science, Vulkam aims to set new benchmarks in metallurgy and metal processing, catering to the growing demand for high-performance, functional components in diverse applications.

Adionics is a Paris-based technology company focused on saline water valorization and desalination. It develops and commercializes processes and chemicals for removing salts from saline sources, including AquaOmnes, a water-desalination technology that extracts salt from salty water to leave fresh water, and Flionex, an ion-absorbing liquid that binds salts. The company serves municipal water, power, oil and gas, and chemical markets. It also develops FLIONEX, a selective extractant for lithium salts, and pursues research to enable lithium recycling from batteries. Its saline water treatment platform uses a chemical-free liquid-liquid extraction with hot water stripping to recover lithium, valuable minerals, or remove impurities from brine, seawater and other saline sources, aiming for cost-effective, low-environmental impact solutions.

Aledia SA, established in 2011, specializes in the development and manufacturing of light-emitting diodes (LEDs). The company's proprietary technology involves a 3D architecture using gallium-nitride-on-silicon microwires, enabling cost-effective production of LED chips at 25% the cost of traditional planar LED chips. Aledia's products cater to general lighting, automotive, and display applications, with a focus on mobile displays and microdisplays for AR/VR devices. Headquartered in Grenoble, France, the company has subsidiaries in Malacca, Malaysia, and Palo Alto, California.

Remedee Labs SAS is a French company founded in 2016, dedicated to developing innovative solutions for chronic pain management. The company has created the Microelectronic Endorphin Trigger (MEET), a personal endorphin stimulator that facilitates on-demand stimulation of the body’s natural endorphins to alleviate pain. Drawing on a decade of pre-clinical and clinical research, Remedee Labs aims to improve the quality of life for the 1.5 billion people worldwide suffering from chronic pain, particularly focusing on conditions such as fibromyalgia. By collaborating with medical practitioners, the company offers a patient-centered digital service platform that enhances the accessibility and effectiveness of endorphin-stimulation therapy for personal healthcare. As it continues to evolve, Remedee Labs plans to expand its platform to address additional chronic pain conditions, positioning itself as a leader in neuromodulation technology for pain management.

Prophesee develops neuromorphic vision systems that mimic the human eye's functionality. Its patented sensors and AI algorithms enable unprecedented speed (>10,000 fps), dynamic range (>120dB), data volume reduction (10x to 1000x), and power efficiency (<10 mW). Prophesee serves clients in autonomous driving, mobile devices, IoT, and industry sectors. Founded in Paris in 2014 by Ryad Benosman, Bernard Gilly, Christoph Posch, and Luca Verre, the company is backed by leading international investors.

Micropep Technologies is an agricultural biotechnology company founded in 2016 and based in Toulouse, France. The company specializes in the development of non-GMO bioherbicides and biostimulants utilizing its innovative miPEP technology, which harnesses naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep focuses on four key development programs: germination, flowering, growth, and weed control, aiming to improve agricultural yields while maintaining the integrity of plant DNA. By leveraging the potential of these biomimetic peptides, Micropep seeks to provide effective solutions for managing plant genetics and enhancing resistance to diseases, thereby supporting sustainable farming practices.

Diabeloop is a medical device company based in Grenoble, France, specializing in innovative solutions for diabetes management. Founded in 2015, the company focuses on developing a closed-loop system that automates insulin delivery for individuals with type 1 diabetes. Its AI-based blood sugar monitoring device integrates a sensor that continuously measures glucose levels, a pump that administers insulin, and a smartphone application that connects these components through an embedded algorithm. This technology aims to enhance the treatment experience by reducing the mental burden on patients, allowing them to manage their condition more effortlessly and live their lives with greater freedom.

Micropep Technologies is an agricultural biotechnology company founded in 2016 and based in Toulouse, France. The company specializes in the development of non-GMO bioherbicides and biostimulants utilizing its innovative miPEP technology, which harnesses naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep focuses on four key development programs: germination, flowering, growth, and weed control, aiming to improve agricultural yields while maintaining the integrity of plant DNA. By leveraging the potential of these biomimetic peptides, Micropep seeks to provide effective solutions for managing plant genetics and enhancing resistance to diseases, thereby supporting sustainable farming practices.

Adionics is a Paris-based technology company focused on saline water valorization and desalination. It develops and commercializes processes and chemicals for removing salts from saline sources, including AquaOmnes, a water-desalination technology that extracts salt from salty water to leave fresh water, and Flionex, an ion-absorbing liquid that binds salts. The company serves municipal water, power, oil and gas, and chemical markets. It also develops FLIONEX, a selective extractant for lithium salts, and pursues research to enable lithium recycling from batteries. Its saline water treatment platform uses a chemical-free liquid-liquid extraction with hot water stripping to recover lithium, valuable minerals, or remove impurities from brine, seawater and other saline sources, aiming for cost-effective, low-environmental impact solutions.

PowerUp Technology designs and markets battery management and optimization solutions for fleets of battery-powered equipment and consumer devices. Its smart chargers determine optimal charging conditions based on battery temperature, state of charge, and degradation, while software continuously monitors state of health, controls charging for individual batteries, and supports fleet management through a web application. The company's solutions apply to railway and other heavy equipment, backup power systems, portable tools, battery-powered personal vehicles, and consumer electronics. It provides lithium-ion battery analytics that diagnose health, enable dynamic charging to extend battery life, and process operational data to help clients identify asset risks and return-on-investment opportunities. PowerUp Technology was founded in 2017 and is based in Aulnay-sous-Bois, France.

Founded in 2011, Ynsect is a biotech company specializing in insect farming and processing. It produces feed for fish and poultry using insects as a sustainable protein source. The company also develops products for non-food applications such as organic fertilizers and bioenergy.

Founded in 2007, Microoled specializes in the design, production, and marketing of OLED microdisplays for near-eye applications. These displays are used in outdoor optical equipment, night vision glasses, medical devices, and augmented reality (AR) glasses.

Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, specializing in the design and production of amorphous metal parts. Founded in 2017, Vulkam focuses on creating biocompatible amorphous metal alloys primarily composed of zirconium, copper, hafnium, nickel, and titanium. The company's innovative products serve various industries, including aerospace, automotive, biomedical, and microcomponents. Vulkam's micromechanical parts are notable for their small size and exceptional strength, offering performance comparable to established industry standards. By leveraging advanced materials science, Vulkam aims to set new benchmarks in metallurgy and metal processing, catering to the growing demand for high-performance, functional components in diverse applications.

Diabeloop is a medical device company based in Grenoble, France, specializing in innovative solutions for diabetes management. Founded in 2015, the company focuses on developing a closed-loop system that automates insulin delivery for individuals with type 1 diabetes. Its AI-based blood sugar monitoring device integrates a sensor that continuously measures glucose levels, a pump that administers insulin, and a smartphone application that connects these components through an embedded algorithm. This technology aims to enhance the treatment experience by reducing the mental burden on patients, allowing them to manage their condition more effortlessly and live their lives with greater freedom.

Remedee Labs SAS is a French company founded in 2016, dedicated to developing innovative solutions for chronic pain management. The company has created the Microelectronic Endorphin Trigger (MEET), a personal endorphin stimulator that facilitates on-demand stimulation of the body’s natural endorphins to alleviate pain. Drawing on a decade of pre-clinical and clinical research, Remedee Labs aims to improve the quality of life for the 1.5 billion people worldwide suffering from chronic pain, particularly focusing on conditions such as fibromyalgia. By collaborating with medical practitioners, the company offers a patient-centered digital service platform that enhances the accessibility and effectiveness of endorphin-stimulation therapy for personal healthcare. As it continues to evolve, Remedee Labs plans to expand its platform to address additional chronic pain conditions, positioning itself as a leader in neuromodulation technology for pain management.

CAILabs SAS is a French deep tech company headquartered in Rennes, specializing in the design, development, and production of photonic solutions aimed at optimizing light utilization in various applications. Established in 2013, CAILabs focuses on innovative optical components, particularly through its patented Multi-Plane Light Conversion (MPLC) technology. The company provides a range of products, including mode multiplexers, light converters, and laser beam shaping solutions tailored for the telecommunications and industrial laser sectors. Its offerings are designed to enhance the performance of fiber optic networks and laser material processing, addressing critical challenges such as atmospheric turbulence and the need for efficient signal multiplexing. CAILabs aims to leverage its expertise and technological innovations to create reliable and cost-effective solutions for clients in the photonics industry.

Keranova S.A., founded in 2015 and based in Saint Etienne, France, with an additional office in Vénissieux, specializes in the design and development of innovative surgical equipment for ophthalmologic procedures, specifically targeting the anterior segment of the eye. The company focuses on creating advanced surgical instruments that utilize a unique patented technology to enhance the efficiency and accuracy of ophthalmic surgeries. By introducing automation into these procedures, Keranova aims to reduce the reliance on manual techniques, offering equipment equipped with vision systems, intelligent software, and precise robotic movements. This approach represents a significant advancement in ophthalmic surgery, allowing for more reproducible outcomes and improved patient care.

NH TherAguix SAS is a clinical-stage pharmaceutical company based in Villeurbanne, France, focused on the development of nanomedicines for cancer treatment. The company specializes in creating innovative therapeutics that enhance radiotherapy for solid tumors. Its lead product, AGuIX, is a theranostic nanoparticle designed to improve the localization of tumors and optimize radiation therapy outcomes. By facilitating intravenous administration, AGuIX enables healthcare professionals to determine the best timing for irradiation, targets tumor tissues more effectively, and minimizes adverse effects on healthy tissues by reducing radiation doses. Founded in 2015, NH TherAguix is dedicated to advancing cancer treatment through its pioneering approach to combining imaging and radiotherapy.

Diota is a company based in Massy, France, specializing in augmented reality (AR) software solutions tailored for industrial applications. Founded in 2009, the company focuses on integrating digital data with human operators to enhance the efficiency of complex industrial processes. Its flagship product, DiotaPlayer, facilitates the use of AR across various industrial sectors, including manufacturing, aerospace, automotive, and oil and gas. The software allows users to browse, interact with, check, report, and track information seamlessly within existing hardware and software environments. Diota’s solutions are compatible with multiple devices, such as tablets and head-mounted displays, making them versatile for different operational needs. Additionally, the company offers consulting, technical support, and training services to optimize the implementation of its technologies. Diota's client base includes major industry players such as Safran Group, Dassault Aviation, and Renault, positioning it as a key contributor to the digital transformation of the industrial landscape in Europe.

Prophesee develops neuromorphic vision systems that mimic the human eye's functionality. Its patented sensors and AI algorithms enable unprecedented speed (>10,000 fps), dynamic range (>120dB), data volume reduction (10x to 1000x), and power efficiency (<10 mW). Prophesee serves clients in autonomous driving, mobile devices, IoT, and industry sectors. Founded in Paris in 2014 by Ryad Benosman, Bernard Gilly, Christoph Posch, and Luca Verre, the company is backed by leading international investors.

Aledia SA, established in 2011, specializes in the development and manufacturing of light-emitting diodes (LEDs). The company's proprietary technology involves a 3D architecture using gallium-nitride-on-silicon microwires, enabling cost-effective production of LED chips at 25% the cost of traditional planar LED chips. Aledia's products cater to general lighting, automotive, and display applications, with a focus on mobile displays and microdisplays for AR/VR devices. Headquartered in Grenoble, France, the company has subsidiaries in Malacca, Malaysia, and Palo Alto, California.